- CSR Summary Not Available
- NCT02139943
- Primary Citation Trial has yet to be published
- Data Specification Not Yet Available
You are not logged in.
Please login to continue selecting trials.
Trial Information
Generic NameCanagliflozinProduct NameINVOKANA®Therapeutic AreaCardiovascular and Metabolic DiseasesEnrollment352% Female43.9%% WhiteN/A
Product ClassKinase InhibitorsSponsor Protocol Number28431754DIA2004 Data PartnerJohnson & JohnsonCondition StudiedDiabetes MellitusMean/Median Age (Years)42.3
Supporting Documentation
- Collected Datasets Available
- Data Definition Specification Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available